Wednesday, September 16, 2026Latest filing Sep 14, 2026

PHG Congressional Stock Trades

Koninklijke Philips N.V. NY Registry Shares (PHG)

Last disclosed trade Feb 12

Every disclosed trade in PHG by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Earl Blumenauer · Bought $PHG · Feb 12 · $1K–$15K

0.45LOW
Disclosure speedx 0.250.60
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.350.70

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $PHG

Get notified when any member of Congress trades $PHG. Free, no card, no spam.

Follow free →
1
Disclosed trades
1
Buys
0
Sells
1
Members trading

The record on $PHG

Coldpine has parsed 1 disclosed trade in $PHG by 1 member of Congress, drawn from 1 periodic transaction report dated Feb 12, 2024. It came from the House, filed by a Democrat.

The one trade with a known filing lag was reported 19 days after the trade date, inside the 45-day window the STOCK Act sets: a $PHG purchase by Earl Blumenauer dated Feb 12, 2024, disclosed Mar 2, 2024. How late filing is measured across all of Congress is in the late-filers study.

The one trade that lists an account holder was reported under a spouse, dependent child, or joint account rather than the member directly.

Members who trade PHG

Recent disclosed trades in PHG

DateMemberTypeAmount
Feb 12Earl Blumenauer(OR)buy$1K–$15K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →